Genetic profiling of dendritic cells exposed to live‐ or ultraviolet‐irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles

Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide for which an effective vaccine is being actively pursued. Current vaccine efforts will be aided by elucidating the interaction between Chlamydia and dendritic cells (DCs). Protective immunity appears to develop slowly following natural infection in humans, and early vaccine trials using inactivated C. trachomatis resulted in partial, short‐lived protection with possible enhanced inflammatory pathology during re‐infection. Thus, immunity following natural infection with live chlamydia may differ fundamentally from immune responses induced by immunization with inactivated chlamydia. We explored this conjecture by studying the response of DCs exposed to either viable or inactivated [ultraviolet (UV) –irradiated] chlamydia elementary bodies (EBs; designated as Live‐EB and UV‐EB, respectively) using Affymetrix GeneChip microarrays. Thirty‐one immunologically characterized genes were differentially expressed by DCs following exposure to Live‐EB or UV‐EB, including two glutamic acid–leucine–arginine cysteine–X–cysteine (ELR CXC) neutrophil chemoattractant chemokines, Cxcl1 (KC), and Cxcl2 (MIP‐2). Up‐regulation of these genes by Live‐EB as compared to UV‐EB was verified by quantitative reverse transcription–polymerase chain reaction and increased chemokine secretion was confirmed by enzyme‐linked immunosorbent assay both in vitro and in vivo. Immunofluorescence and fluorescence‐activated cell sorter analysis of chlamydia‐infected lung tissue confirmed that Live‐EB but not UV‐EB induced significant DC and neutrophil infiltration during infection. These observations demonstrate that the development of an antichlamydial immune response is dramatically influenced by chlamydial viability. This has implications as to why early inactivated chlamydial vaccines were ineffective and suggests that new vaccine design efforts may benefit from in vitro DC screening for ELR chemokine expression profiles.

[1]  C. Caux,et al.  Dendritic cell biology and regulation of dendritic cell trafficking by chemokines , 2009, Springer Seminars in Immunopathology.

[2]  R. Brunham,et al.  The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. , 2005, The Journal of infectious diseases.

[3]  H. Ueno,et al.  Human Dendritic Cell Subsets for Vaccination , 2005, Journal of Clinical Immunology.

[4]  T. Darville.  Chlamydia trachomatis infections in neonates and young children. , 2005, Seminars in pediatric infectious diseases.

[5]  Hua Tang,et al.  Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. , 2005, Blood.

[6]  M. Matyszak,et al.  Infection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-gamma production by human natural killer cells. , 2005, FEMS immunology and medical microbiology.

[7]  D. Maskell,et al.  Activation of murine dendritic cells and macrophages induced by Salmonella enterica serovar Typhimurium , 2005, Immunology.

[8]  Theresa M. Ames,et al.  CCR2 and CCR6, but Not Endothelial Selectins, Mediate the Accumulation of Immature Dendritic Cells within the Lungs of Mice in Response to Particulate Antigen12 , 2005, The Journal of Immunology.

[9]  Elaine Y Fukuda,et al.  Up-Regulation of the JAK/STAT1 Signal Pathway during Chlamydia trachomatis Infection1 , 2005, The Journal of Immunology.

[10]  U. Heinzmann,et al.  Polymorphonuclear Neutrophils Improve Replication of Chlamydia pneumoniae In Vivo upon MyD88-Dependent Attraction1 , 2005, The Journal of Immunology.

[11]  H. Moll,et al.  Leishmania major Modulates Chemokine and Chemokine Receptor Expression by Dendritic Cells and Affects Their Migratory Capacity , 2005, Infection and Immunity.

[12]  R. Brunham,et al.  A Live and Inactivated Chlamydia trachomatis Mouse Pneumonitis Strain Induces the Maturation of Dendritic Cells That Are Phenotypically and Immunologically Distinct , 2005, Infection and Immunity.

[13]  Xiaobin Han,et al.  Intranasal inoculation of Chlamydia trachomatis mouse pneumonitis agent induces significant neutrophil infiltration which is not efficient in controlling the infection in mice , 2005, Immunology.

[14]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[15]  L. Slatt,et al.  Sexually Transmitted Infections and Increased Risk of Co-infection with Human Immunodeficiency Virus , 2004, The Journal of the American Osteopathic Association.

[16]  R. Suchland,et al.  Differential Regulation of Inflammatory Cytokine Secretion by Human Dendritic Cells upon Chlamydia trachomatis Infection , 2004, Infection and Immunity.

[17]  A. Eley,et al.  Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. , 2004, Journal of medical microbiology.

[18]  T. Ellis,et al.  Interferon‐γ activation of polymorphonuclear neutrophil function , 2004 .

[19]  G. Dougan,et al.  Live Salmonella enterica serovar Typhimurium (S. Typhimurium) elicit dendritic cell responses that differ from those induced by killed S. Typhimurium. , 2004, Veterinary immunology and immunopathology.

[20]  T. Ellis,et al.  Interferon-gamma activation of polymorphonuclear neutrophil function. , 2004, Immunology.

[21]  D. Guiney,et al.  Helicobacter pylori Preferentially Induces Interleukin 12 (IL-12) Rather than IL-6 or IL-10 in Human Dendritic Cells , 2003, Infection and Immunity.

[22]  H. Heine,et al.  Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. , 2003, European journal of biochemistry.

[23]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[24]  Y. Iwakura,et al.  Effective Induction of Acquired Resistance to Listeria monocytogenes by Immunizing Mice with In Vivo-Infected Dendritic Cells , 2003, Infection and Immunity.

[25]  R. Stephens.  The cellular paradigm of chlamydial pathogenesis. , 2003, Trends in microbiology.

[26]  R. Brunham,et al.  GM-CSF Transgene-Based Adjuvant Allows the Establishment of Protective Mucosal Immunity Following Vaccination with Inactivated Chlamydia trachomatis1 , 2002, The Journal of Immunology.

[27]  K. Andrassy,et al.  Up‐regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease , 2002, Clinical and experimental immunology.

[28]  H. Caldwell,et al.  Immunity to Murine Chlamydial Genital Infection , 2002, Infection and Immunity.

[29]  D. Crane,et al.  Dendritic Cells Pulsed with a Recombinant Chlamydial Major Outer Membrane Protein Antigen Elicit a CD4+ Type 2 Rather than Type 1 Immune Response That Is Not Protective , 2002, Infection and Immunity.

[30]  L. Santambrogio,et al.  RANTES-Induced Chemokine Cascade in Dendritic Cells1 , 2001, The Journal of Immunology.

[31]  H. Caldwell,et al.  Expression of Genes Encoding Th1 Cell-Activating Cytokines and Lymphoid Homing Chemokines by Chlamydia-Pulsed Dendritic Cells Correlates with Protective Immunizing Efficacy , 2001, Infection and Immunity.

[32]  Ilkka Julkunen,et al.  Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1 , 2001, The Journal of Immunology.

[33]  C. Andrews,et al.  Early Local Cytokine Profiles in Strains of Mice with Different Outcomes from Chlamydial Genital Tract Infection , 2001, Infection and Immunity.

[34]  R. Brunham,et al.  Human Immunodeficiency Virus Type 1—Infected Women Exhibit Reduced Interferon-γ Secretion after Chlamydia trachomatis Stimulation of Peripheral Blood Lymphocytes , 2000 .

[35]  K. Andrassy,et al.  Polymorphonuclear neutrophils as accessory cells for T‐cell activation: major histocompatibility complex class II restricted antigen‐dependent induction of T‐cell proliferation , 2000, Immunology.

[36]  P. Wyrick,et al.  Chlamydial infection of polarized HeLa cells induces PMN chemotaxis but the cytokine profile varies between disseminating and non‐disseminating strains , 2000, Cellular microbiology.

[37]  S. Morrison,et al.  In Situ Analysis of the Evolution of the Primary Immune Response in Murine Chlamydia trachomatis Genital Tract Infection , 2000, Infection and Immunity.

[38]  S. Salzberg,et al.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. , 2000, Nucleic acids research.

[39]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[40]  GLOBAL PREVALENCE AND INCIDENCE OF SELECTED CURABLE SEXUALLY TRANSMITTED DISEASES: OVERVIEW AND ESTIMATES , 2000 .

[41]  R. Brunham,et al.  Human immunodeficiency virus type 1-infected women exhibit reduced interferon-gamma secretion after Chlamydia trachomatis stimulation of peripheral blood lymphocytes. , 2000, The Journal of infectious diseases.

[42]  R. Brunham,et al.  IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. , 1999, Journal of immunology.

[43]  G. Zhong,et al.  Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. , 1999, Infection and immunity.

[44]  P. Kosma.  Chlamydial lipopolysaccharide. , 1999, Biochimica et biophysica acta.

[45]  O. Majdic,et al.  Neutrophil Granulocyte–committed Cells Can Be Driven to Acquire Dendritic Cell Characteristics , 1998, The Journal of experimental medicine.

[46]  M. Kagnoff,et al.  Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. , 1997, The Journal of clinical investigation.

[47]  E. Peterson,et al.  Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection , 1996, Infection and immunity.

[48]  F. Lanza,et al.  Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes , 1996, Journal of leukocyte biology.

[49]  R. Peeling,et al.  Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. , 1996, The Journal of infectious diseases.

[50]  H. Whittle,et al.  Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls , 1995, Infection and immunity.

[51]  P. Piot,et al.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. , 1993 .

[52]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[53]  R. Woodland,et al.  Animal models of chlamydial infection. , 1983, British medical bulletin.

[54]  Grayston Jt,et al.  The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. , 1978 .

[55]  S. Wang,et al.  The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. , 1978, Sexually transmitted diseases.

[56]  J. Grayston,et al.  Pathogenesis and immunology of trachoma. , 1972, Transactions of the Association of American Physicians.

[57]  E. Alexander,et al.  Trachoma vaccine studies in monkeys. , 1967, American journal of ophthalmology.